Tubulis
Tubulis generates uniquely matched antibody-drug conjugates (ADCs) using proprietary platform technologies. The company's pipeline includes lead ADC candidates, TUB-040 and TUB-030, which are being evaluated in the clinic for high-need solid tumor indications. Tubulis innovates on all aspects of ADC design to expand the therapeutic potential of this drug class for patients.
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does Tubulis use?+
Tubulis uses 15 technologies including Borlabs Cookie, Elementor, Swiper.
What industry is Tubulis in?+
Tubulis operates in the Biotechnology industry.
Where is Tubulis based?+
Tubulis is headquartered in Germany.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026